Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals, Inc.

INFIQ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$9.08K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Infinity Pharmaceuticals, Inc.Infinity Pharmaceuticals, Inc.0-108%--0.2

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$9,076.00
Enterprise Value$-8,827,924.00
Earnings per Share$-0.5
Beta8.97
Outstanding Shares89,885,492

Return

Return on Equity108.35%ROE
Return on Assets-190.90%
Return on Invested Capital-458.62%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-3.44
Enterprise Value to EBIT0.21
Enterprise Value to Net Income0
Total Debt to Enterprise-1.01
Debt to Equity-0.24Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 19, 2026
EPS Estimate
-$0.13
Consensus analyst estimate
Revenue Estimate
$1.28 M
Consensus analyst estimate

Next Earnings Call

Expected Date
March 31, 2027
EPS Estimate
-$0.14
Consensus analyst estimate
Revenue Estimate
$239,429
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Infinity Pharmaceuticals Inc.

30 employees
CEO: Adelene Perkins

Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549), an orally administered clinical-st...